Last reviewed · How we verify
NCT05503277
A RANDOMIZED CONTROLED TRAIL COMARING LARYNGEAL TUBE SUCTION DISPOSABLE AND I-gel IN PEDIATRIC PATIENT
NA trial testing LTSD in Seal Pressure in 100 participants. Status unknown.
1 November 2023
Quick facts
| Lead sponsor | Bnai Zion Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 100 |
| Start date | 1 November 2022 |
| Primary completion | 1 November 2023 |
| Estimated completion | 31 December 2023 |
Drugs / interventions tested
- LTSD
- i-gel
Conditions studied
- Seal Pressure — all drugs for Seal Pressure →
Sponsor
Bnai Zion Medical Center
Who can join
Adults 2 to 10, any sex, with Seal Pressure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction The Laryngeal Tube Suction Disposable LTS-D and the i-gel are a second generation supraglottic airway device SAD, the devices have a drain tube to allow access to the gastrointestinal. The i-gel is a second generation SAD. Does not need an inflatable cuff because the thermoplastic elastomer provides the seal. The study designs to compare the Oropharyngeal leak pressure (OLP) of LTS-D with the i-gel that allow the use of Pressure Control Ventilation. Materials and methods Approval obtained from the institute Ethics Committee, No 0117-22-BNZ. Written parental consent will be obtained Hundred children (50 patients in each device of both sex, weighing 10-35 kg, with an ASA physical status I, scheduled for elective minor surgery Study design Devices are the pediatric LTS-D and the i-gel. The patients will fast for 6 h for solids and 2 h for clear fluids and will be unpremeditated, anesthesia will initiate following a standardized protocol. Both devices will be inserted blindly by expert pediatric anesthesiologists. Leak pressure, will be determined by closing the expiratory valve of the anesthesia breathing system and a fixed gas flow of 3 l min-1. The airway pressure at which an equilibrium is reached will be noted (maximum 40 cm H2O). Primary outcome: Leak pressure Secondary outcome: SGAD insertion time Fiberoptic view Maneuvers Complications. Statistical Analysis the primary outcome is the leak pressure. Previous pilot conducted in 15 children, the average standard deviation leak pressure found to be 31 cm H20. In order to obtain a statistically representative sample for a 95% CI with a margin error of 2% and a standard deviation of 2 cm H20, the sample sizes of 50 cases are needed for each device. Continuous data presented as mean±SD. For the categorical variables frequencies and percentages will be calculated. SPSS version 20 for statistical analysis. P-values smaller than 0.05 considered statistically significant. Categorical data will be analyzed with Pearson chi-square test Mann-Whitney U test will be performed to analyze non-normally distributed interval scale data and ordinal categorical data. Normally distributed data will be analyzed by t-tests.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of LTS-D and i-gel in non-paralyzed pediatric patients under general anesthesia: a randomized trial.
Somri M, Somri F, Gaitini L, Safadi A, et al · · 2025 · PMID 41039946 · DOI 10.5114/ait/208942
Verify or expand the search:
- PubMed search for NCT05503277
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Bnai Zion Medical Center trials
Trials by the same sponsor.
- NCT07323901 — GRAPE-GDM Prospective Comperative Trial - Grape Juice as a Replacement Drink for Gestational Diabetes Screening · NA · enrolling by invitation
- NCT06487169 — Effectivity Gas Extraction to Prevent Anesthesiologists Waste Gas Exposure of Sevofluorane During Pediatric Induction · not yet recruiting
- NCT06581185 — Pseudotumor Cerebri Headache Ten Years Outcome · enrolling by invitation
- NCT07288021 — Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE) · Phase 4 · recruiting
- NCT06190964 — Integrative Medicine for Hospital Workers Exposed to War · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05503277 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bnai Zion Medical Center
- Last refreshed: 16 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05503277.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing